BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6129649)

  • 41. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
    Wolf R
    Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
    Karniol IG; Portela W
    Braz J Med Biol Res; 1982 Dec; 15(6):389-94. PubMed ID: 6135468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroleptic malignant syndrome superimposed on tardive dyskinesia.
    Haggerty JJ; Bentsen BS; Gillette GM
    Br J Psychiatry; 1987 Jan; 150():104-5. PubMed ID: 2888500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined treatment of tardive dyskinesia with clonidine and neuroleptics: a follow-up study of three cases for three years.
    Nishikawa T; Tanaka M; Koga I; Uchida Y
    Psychopharmacology (Berl); 1983; 80(4):374-5. PubMed ID: 6137858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tardive dyskinesia and treatment of psychosis after withdrawal of neuroleptics.
    Baskett SJ
    Brain Res Bull; 1983 Aug; 11(2):173-4. PubMed ID: 6138132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of complaints in schizophrenics with tardive dyskinesia.
    Alexopoulos GS
    J Nerv Ment Dis; 1979 Feb; 167(2):125-7. PubMed ID: 33230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.
    Barak Y; Swartz M; Shamir E; Stein D; Weizman A
    Ann Clin Psychiatry; 1998 Sep; 10(3):101-5. PubMed ID: 9781472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia.
    Kashihara K; Ebara T; Yamamoto M; Ogawa T; Harada T; Otsuki S
    Folia Psychiatr Neurol Jpn; 1985; 39(2):147-53. PubMed ID: 2866149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor.
    Pöldinger W
    Int Pharmacopsychiatry; 1978; 13(4):230-3. PubMed ID: 32149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium valproate and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Jul; 133():82. PubMed ID: 352469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonidine therapy for tardive dyskinesia and related syndromes.
    Nishikawa T; Tanaka M; Tsuda A; Koga I; Uchida Y
    Clin Neuropharmacol; 1984; 7(3):239-45. PubMed ID: 6488198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
    Häggström JE
    Acta Psychiatr Scand Suppl; 1984; 311():103-8. PubMed ID: 6142586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of sultopride in a case of neuroleptic-induced late dyskinesia].
    Leclere A; Plichart P
    Sem Hop; 1982 Nov; 58(42):2492-3. PubMed ID: 6130603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of amantadine and neuroleptics plus time may cure tardive dyskinesia.
    Ankenman R
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):96-7. PubMed ID: 2577721
    [No Abstract]   [Full Text] [Related]  

  • 55. Bromocriptine for "negative" schizophrenia.
    Levi-Minzi S; Bermanzohn PC; Siris SG
    Compr Psychiatry; 1991; 32(3):210-6. PubMed ID: 1679383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of two benzodiazepines ("diazepam" versus "nitrazepam") in the treatment of postneuroleptic tardive dyskinesia.
    Sârbulescu A; Alexandrescu L; Georgescu MJ
    Neurol Psychiatr (Bucur); 1986; 24(3):189-93. PubMed ID: 2877486
    [No Abstract]   [Full Text] [Related]  

  • 57. Is bromocriptine a dopamine antagonist treatment?
    Lieberman J; Lesser M; Brenner R
    Arch Gen Psychiatry; 1983 Apr; 40(4):469-70. PubMed ID: 6838329
    [No Abstract]   [Full Text] [Related]  

  • 58. A 10-year follow-up study of tardive dyskinesia--with special reference to the influence of neuroleptic administration on the long-term prognosis.
    Yagi G; Itoh H
    Keio J Med; 1985 Dec; 34(4):211-9. PubMed ID: 2872356
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.
    Stevens E; Roman A; Houa M; Razavi D; Jaspar N
    Intensive Care Med; 1998 Apr; 24(4):369-71. PubMed ID: 9609418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bromocriptine.
    Roehrich H; Dackis CA; Gold MS
    Med Res Rev; 1987; 7(2):243-69. PubMed ID: 3553782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.